These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 26404377)

  • 1. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
    Luvisetto S; Gazerani P; Cianchetti C; Pavone F
    Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
    Sycha T; Kranz G; Auff E; Schnider P
    J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin: A review of the mode of action in migraine.
    Do TP; Hvedstrup J; Schytz HW
    Acta Neurol Scand; 2018 May; 137(5):442-451. PubMed ID: 29405250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study.
    Siongco PRL; Rosales RL; Moore AP; Freynhagen R; Arimura K; Kanovsky P; Kaji R; Fernandez HH; Dressler D
    J Neural Transm (Vienna); 2020 Jun; 127(6):935-951. PubMed ID: 32146504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A and neuropathic pain: An update.
    Spagna A; Attal N
    Toxicon; 2023 Aug; 232():107208. PubMed ID: 37385479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
    Blumenfeld AM; Dodick DW; Silberstein SD
    Dermatol Clin; 2004 Apr; 22(2):167-75. PubMed ID: 15222577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
    Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
    J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
    Freitag FG
    CNS Drugs; 2003; 17(6):373-81. PubMed ID: 12696998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Göbel H; Heinze A; Heinze-Kuhn K; Austermann K
    Nervenarzt; 2001 Apr; 72(4):261-74. PubMed ID: 11320861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW
    Headache; 2003; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential antinociceptive mechanisms of botulinum toxin].
    Aoki KR; Francis J; Jost WH
    Schmerz; 2006 Sep; 20(5):381-2, 384-7. PubMed ID: 16819667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of therapy effects by botulinum neurotoxin].
    Alajbegović A; Alajbegović S; Resić H
    Med Arh; 2008; 62(1):53-5. PubMed ID: 18543757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of botulinum toxin for pain therapy].
    Nodera H
    Brain Nerve; 2008 May; 60(5):503-8. PubMed ID: 18516972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
    Oh HM; Chung ME
    Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OnabotulinumtoxinA Reduces Temporal Pain Processing at Spinal Level in Patients with Lower Limb Spasticity.
    De Icco R; Perrotta A; Berra E; Allena M; Alfonsi E; Tamburin S; Serrao M; Sandrini G; Tassorelli C
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31226803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients.
    Schim J
    Curr Med Res Opin; 2004 Jan; 20(1):49-53. PubMed ID: 14741072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache.
    Göbel H; Heinze A; Heinze-Kuhn K; Jost WH
    J Neurol; 2001 Apr; 248 Suppl 1():34-8. PubMed ID: 11357239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
    Bono F; Mazza MR; Magro G; Spano G; Idone G; Laterza V; Tedeschi D; Pucci F; Gambardella A; Sarica A
    Toxins (Basel); 2023 May; 15(5):. PubMed ID: 37235358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications and management of botulinum toxin].
    Singer C
    Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.
    Schulte-Mattler WJ
    CNS Drugs; 2008; 22(9):725-38. PubMed ID: 18698873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.